Update on Rotavirus Vaccine Supplies

Dear partners and colleagues,

We have recently received a growing number of inquiries regarding the availability of the rotavirus vaccine. We fully appreciate how critical this product is to the healthcare system and would like to take this opportunity to address the current situation.

PHARM AID is duly meeting its commitments for this year's planned vaccine supply volumes under existing contracts with state purchasers. The forward delivery schedule will be adjusted based on customer requirements and mutually agreed timelines.

At present, logistics have become more complex and require additional coordination at certain stages of the supply chain. At the same time, PHARM AID is taking every necessary step to ensure that these changes do not affect medical institutions or end users, and that deliveries remain as consistent and predictable as possible.

Please note that PHARM AID does not engage in retail sales of vaccines and does not accept orders from individuals. We are also unable to provide information on stock availability at pharmacies or clinics, as our operations are strictly B2B and contract-based. For questions about on-the-ground availability, we kindly ask you to contact your local pharmacies or medical facilities directly.

We would also like to inform you that the registration process for a liquid form of the rotavirus vaccine is currently underway. For our company, this is an important area of focus, aimed at improving access to modern preventive products and developing long-term solutions for the Russian market.

We appreciate the continued trust of our partners and will keep working to maintain a stable supply, respond to customer needs, and support vaccination efforts across the healthcare system.